Products/Services Used | Details | Operation |
---|---|---|
Biochemicals> | 1) and its mutations were obtained from GenScript USA Incorporated, New Jersey, namely: TRPV1 – CT proximal region K688-K718 (pTRPV1–CTp) (KIAQES- KNIWKLQRAITILDTEKSFLKCMRK), TRPV1 – CT proxi- mal region K688-K718 possessing mutations of K694A/K698A/ K710A (KIAQESANIWALQRAITILDTEASFLKCMRK), TRPV1 – CT proximal region K688-K718 possessing mutations of Q700A/R701A (KIAQESKNIWKLAAAITILD- TEKSFLKCMRK), TRPV1 – CT distal region L777-S820 (pTRPV1 – CTd) (LRSGRVSGRNWKNFALVPLLRT- DASTRDRHATQQEEVQLKHYTGS), TRPV1 – NT region F189-V221 (pTRPV1 – NT) (FVNASYTDSYYKGQTAL- HIAIERRNMTLVTLLV). | Get A Quote |
TRPV1 is a nonselective cation channel that integrates wide range of painful stimuli. It has been shown that its activity could be modulated by intracellular ligands PIP2 or calmodulin (CaM). The detailed localization and description of PIP2 interaction sites remain unclear. Here, we used synthesized peptides and purified fusion proteins of intracellular regions of TRPV1 expressed in E.coli in combination with fluorescence anisotropy and surface plasmon resonance measurements to characterize the PIP2 binding to TRPV1. We characterized one PIP2 binding site in TRPV1 N-terminal region, residues F189-V221, and two independent PIP2 binding sites in C-terminus: residues K688-K718 and L777-S820. Moreover we sho... More